
Rong Le
Examiner (ID: 6693, Phone: (571)270-7637 , Office: P/2423 )
| Most Active Art Unit | 2421 |
| Art Unit(s) | 2423, 2421 |
| Total Applications | 494 |
| Issued Applications | 304 |
| Pending Applications | 67 |
| Abandoned Applications | 142 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9212704
[patent_doc_number] => 20140011881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 14/022789
[patent_app_country] => US
[patent_app_date] => 2013-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29145
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14022789
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/022789 | NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST; AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | Sep 9, 2013 | Abandoned |
Array
(
[id] => 12523740
[patent_doc_number] => 10004744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => Therapeutic approaches for treating Parkinson's disease
[patent_app_type] => utility
[patent_app_number] => 14/425926
[patent_app_country] => US
[patent_app_date] => 2013-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12626
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14425926
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/425926 | Therapeutic approaches for treating Parkinson's disease | Sep 3, 2013 | Issued |
Array
(
[id] => 9212593
[patent_doc_number] => 20140011771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'S1P3 RECEPTOR INHIBITORS FOR TREATING PAIN'
[patent_app_type] => utility
[patent_app_number] => 14/017408
[patent_app_country] => US
[patent_app_date] => 2013-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15565
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14017408
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/017408 | S1P3 RECEPTOR INHIBITORS FOR TREATING PAIN | Sep 3, 2013 | Abandoned |
Array
(
[id] => 9339722
[patent_doc_number] => 20140066504
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'ANALOGS AND PRODRUGS OF BUMETANIDE; COMPOSITIONS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 14/017242
[patent_app_country] => US
[patent_app_date] => 2013-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4820
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14017242
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/017242 | ANALOGS AND PRODRUGS OF BUMETANIDE; COMPOSITIONS AND METHODS OF USE | Sep 2, 2013 | Abandoned |
Array
(
[id] => 12111859
[patent_doc_number] => 09867837
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-16
[patent_title] => 'Compositions for treating neurological disorders'
[patent_app_type] => utility
[patent_app_number] => 14/014650
[patent_app_country] => US
[patent_app_date] => 2013-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 73
[patent_no_of_words] => 23067
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14014650
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/014650 | Compositions for treating neurological disorders | Aug 29, 2013 | Issued |
Array
(
[id] => 9331156
[patent_doc_number] => 20140057937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'ANTAGONISTS OF CHEMOKINE RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 14/011174
[patent_app_country] => US
[patent_app_date] => 2013-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41314
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14011174
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/011174 | Antagonists of chemokine receptors | Aug 26, 2013 | Issued |
Array
(
[id] => 9902051
[patent_doc_number] => 20150057251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-26
[patent_title] => 'COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN'
[patent_app_type] => utility
[patent_app_number] => 14/010455
[patent_app_country] => US
[patent_app_date] => 2013-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7438
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14010455
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/010455 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN | Aug 25, 2013 | Abandoned |
Array
(
[id] => 9339685
[patent_doc_number] => 20140066467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'USE OF OPIOID ANTAGONISTS TO ATTENUATE ENDOTHELIAL CELL PROLIFERATION AND MIGRATION'
[patent_app_type] => utility
[patent_app_number] => 13/972122
[patent_app_country] => US
[patent_app_date] => 2013-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 18625
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13972122
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/972122 | Use of opioid antagonists to attenuate endothelial cell proliferation and migration | Aug 20, 2013 | Issued |
Array
(
[id] => 9212654
[patent_doc_number] => 20140011831
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-09
[patent_title] => 'USE OF OPIOID ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 13/972129
[patent_app_country] => US
[patent_app_date] => 2013-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 21086
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13972129
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/972129 | Use of opioid antagonists | Aug 20, 2013 | Issued |
Array
(
[id] => 9397040
[patent_doc_number] => 20140094446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-03
[patent_title] => 'Cyclic Amino Acids for the Treatment of Pain'
[patent_app_type] => utility
[patent_app_number] => 13/953373
[patent_app_country] => US
[patent_app_date] => 2013-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11544
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13953373
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/953373 | Cyclic Amino Acids for the Treatment of Pain | Jul 28, 2013 | Abandoned |
Array
(
[id] => 9570098
[patent_doc_number] => 20140187810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'STABILIZED COMPOSITIONS OF ALKYLATING AGENTS AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/930535
[patent_app_country] => US
[patent_app_date] => 2013-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21557
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13930535
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/930535 | STABILIZED COMPOSITIONS OF ALKYLATING AGENTS AND METHODS OF USING SAME | Jun 27, 2013 | Abandoned |
Array
(
[id] => 9108311
[patent_doc_number] => 20130281443
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'INHIBITORS OF FOCAL ADHESION KINASE'
[patent_app_type] => utility
[patent_app_number] => 13/921663
[patent_app_country] => US
[patent_app_date] => 2013-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34212
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13921663
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/921663 | Inhibitors of focal adhesion kinase | Jun 18, 2013 | Issued |
Array
(
[id] => 10147847
[patent_doc_number] => 09180111
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-10
[patent_title] => 'Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof'
[patent_app_type] => utility
[patent_app_number] => 13/921876
[patent_app_country] => US
[patent_app_date] => 2013-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 28246
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13921876
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/921876 | Reduction in complement activation and inflammation during tissue injury by carotenoids, carotenoid analogs, or derivatives thereof | Jun 18, 2013 | Issued |
Array
(
[id] => 10541727
[patent_doc_number] => 09266838
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-23
[patent_title] => 'Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/921895
[patent_app_country] => US
[patent_app_date] => 2013-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43003
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13921895
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/921895 | Substituted (E)-N′-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors | Jun 18, 2013 | Issued |
Array
(
[id] => 9192109
[patent_doc_number] => 20130331424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-12
[patent_title] => 'ANTIMICROBIAL COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/913912
[patent_app_country] => US
[patent_app_date] => 2013-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13869
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13913912
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/913912 | Antimicrobial compounds, compositions and methods of use thereof | Jun 9, 2013 | Issued |
Array
(
[id] => 9491787
[patent_doc_number] => 20140142193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'Stabilized Compositions Of Alkylating Agents And Methods Of Using Same'
[patent_app_type] => utility
[patent_app_number] => 13/911217
[patent_app_country] => US
[patent_app_date] => 2013-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15241
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13911217
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/911217 | Stabilized Compositions Of Alkylating Agents And Methods Of Using Same | Jun 5, 2013 | Abandoned |
Array
(
[id] => 9518999
[patent_doc_number] => 20140155491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'Stabilized Compositions of Volatile Alkylating Agents and Methods of Using Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/911282
[patent_app_country] => US
[patent_app_date] => 2013-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10970
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13911282
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/911282 | Stabilized Compositions of Volatile Alkylating Agents and Methods of Using Thereof | Jun 5, 2013 | Abandoned |
Array
(
[id] => 11211927
[patent_doc_number] => 09440954
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-13
[patent_title] => 'Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/909222
[patent_app_country] => US
[patent_app_date] => 2013-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25389
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13909222
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/909222 | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors | Jun 3, 2013 | Issued |
| 13/909555 | METHODS OF TREATING HYPERCHOLESTEROLEMIA | Jun 3, 2013 | Abandoned |
Array
(
[id] => 10001413
[patent_doc_number] => 09045492
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-02
[patent_title] => 'Piperazine compounds'
[patent_app_type] => utility
[patent_app_number] => 13/901479
[patent_app_country] => US
[patent_app_date] => 2013-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65661
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13901479
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/901479 | Piperazine compounds | May 22, 2013 | Issued |